Georgetown University LogoGeorgetown University Library LogoDigitalGeorgetown Home
    • Login
    View Item 
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Biomedical Graduate Education
    • Department of Microbiology and Immunology
    • Graduate Theses and Dissertations - Microbiology & Immunology
    • View Item
    •   DigitalGeorgetown Home
    • Georgetown University Institutional Repository
    • Georgetown University Medical Center
    • Biomedical Graduate Education
    • Department of Microbiology and Immunology
    • Graduate Theses and Dissertations - Microbiology & Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Amino-acid derived 1,2 benzisothiazolinone derivatives as novel small molecule antifungal inhibitors: Characterization and identification of potential genetic targets

    Cover for Amino-acid derived 1,2 benzisothiazolinone derivatives as novel small molecule antifungal inhibitors: Characterization and identification of potential genetic targets
    View/Open
    View/Open: Alex_georgetown_0076D_11419.pdf (1.3MB) Bookview

    Creator
    Alex, Deepu
    Advisor
    Calderone, Richard A
    Abstract
    A steady increase in the incidence of fungal infections has been observed over the past few decades, and treatment remains challenging especially for immuno-compromised populations. Identification of the ideal therapeutic agent to treat fungal infections still remains elusive. Such an agent would need to have broad antifungal activity, low rates of resistance and minimal adverse effects. Since none of the current drugs fulfill the criteria for an ideal agent, it is imperative to identify novel drug candidates. In the course of screening for antifungal compounds, a scaffold of synthetic compounds with antifungal activity was discovered. These compounds have no structural similarity to any existing antifungal compound. 4 amino-acid derived 1,2 benzisothiazolinone derivatives (BD-I-132/DFD-VI-15, BD-I-186, DFD-V-49 and DFD-V-66) show anti-fungal activity against Candida sp., Aspergillus fumigatus, Cryptococcus neoformans and dermatophytes at MIC-50 concentrations in the range of 0.8-12.5 microg/ml. All compounds were fungicidal against Candida sp. The compounds also maintained their MIC-50 values against azole, polyene and echinocandin-resistant strains of Candida sp. The MICs of the compounds were also unaffected by strains that over-expressed drug efflux pumps. A genetics based approach which involves the use of a homozygous deletion collection of approximately 4700 Saccharomyces cerevisiae mutants was used to identify potential gene targets of DFD-VI-15. All mutants were treated with a) suboptimal levels of compound to identify hypersensitive strains and b) fungicidal concentrations of compound to identify resistant strains. 32 mutants were found to be hypersensitive compared to parent strain, BY4743. Also, 96 mutants showed resistance to this compound. Both clusters identified mutants that were essential to mitochondrial function. Saccharomyces and Candida strains (BY4743 and CAF2) were grown in the absence of oxygen and found to be insensitive to the compound. Also, both strains were hypersensitive to DFD-VI-15 when grown on a non-fermentable carbon source like glycerol. Flowcytometry experiments show that DFD-VI-15 treated Candida strains have higher ROS levels when compared to non-treated strains. This suggests that the DFD-VI-15 exerts its antifungal effect by affecting mitochondrial function.
    Description
    Ph.D.
    Permanent Link
    http://hdl.handle.net/10822/558135
    Date Published
    2011
    Subject
    antifungal; benzisothiazolinone; candida; drug discovery; mitochondria; resistance; Microbiology; Medicine; Microbiology; Medicine;
    Type
    thesis
    Publisher
    Georgetown University
    Extent
    184 leaves
    Collections
    • Graduate Theses and Dissertations - Microbiology & Immunology
    Metadata
    Show full item record

    Related items

    Showing items related by title, author, creator and subject.

    • Cover for EWS-­FLI1 as a molecular target: Small molecule inhibitors for a disordered protein

      EWS-­FLI1 as a molecular target: Small molecule inhibitors for a disordered protein 

      Barber-Rotenberg, Julie (Georgetown University, 2012)
      Ewing sarcoma family of tumors (ESFT) consists of highly malignant tumors of the bone and soft tissue. Ninety-five percent of cases contain a balanced t(11;22) or t(21;22) rearrangement, combining the amino-terminus of ...
    Related Items in Google Scholar

    Georgetown University Seal
    ©2009 - 2022 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility
     

     

    Browse

    All of DigitalGeorgetownCommunities & CollectionsCreatorsTitlesBy Creation DateThis CollectionCreatorsTitlesBy Creation Date

    My Account

    Login

    Statistics

    View Usage Statistics

    Georgetown University Seal
    ©2009 - 2022 Georgetown University Library
    37th & O Streets NW
    Washington DC 20057-1174
    202.687.7385
    digitalscholarship@georgetown.edu
    Accessibility